Zika Virus: Epidemiology, Virology, and Counter Measures

Video

At IDWeek 2016, Mark Mulligan, MD, Hope Clinic at Emory Vaccine Center discussed his team's recent projects studying the natural history of Zika infection and their Zika vaccine trial.

At IDWeek 2016, Mark Mulligan, MD, Hope Clinic at Emory Vaccine Center discussed his team's recent projects studying the natural history of Zika infection and their Zika vaccine trial. In their study of US travelers (residents of Atlanta) who went to Zika - affected areas and became ill, Mulligan and team look at the levels of virus in various body fluids and also study their immune responses. Mulligan said that the point of studying Zika's history is to get fundamental information to better design and develop counter measures that are vaccines, treatments, and diagnostic tests. He explained the primary need is to develop vaccines for women and pregnant women, and that it's also important to start thinking of Zika as a sexually transmitted infection.

Related Videos
HCPLive Five at ACC 2024 | Image Credit: HCPLive
Ankeet Bhatt, MD, MBA | Credit: X.com
Ankeet Bhatt, MD, MBA | Credit: X.com
Sara Saberi, MD | Credit: University of Michigan
Muthiah Vaduganathan, MD, MPH | Credit: Brigham and Women's Hospital
Veraprapas Kittipibul, MD | Credit: X.com
Addressing HS Risks at the Genetic Level, with Kai Li, BSc
Building a Psoriasis Knockout Regimen Around Risankizumab, with Andrew Blauvelt, MD, MBA
© 2024 MJH Life Sciences

All rights reserved.